ESR1 and breast carcinoma: To determine the potential estrogenic profile of the synthesized compound with the most relevant anti-proliferative activity (steroid 11), its cell growing effect was measured on the estrogen-sensitive breast cancer T47-D cells (ER+) in serum-free culture medium.